ClinicalTrials.govpublic full text
Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC
small cell lung cancer extensive stage, es-sclc, extensive stage-small cell lung cancer, adebrelimab, irinotecan liposome (ii), zhou chengzhi, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846620
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.